Privi Speciality Chemicals Limited has informed the Exchange regarding Board meeting held on November 05, 2025.
PRIVISCL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Privi Speciality Chemicals announced its unaudited Q2 FY26 and H1 FY26 (ended September 30, 2025) results, approved by the board on November 5, 2025. On a consolidated basis, H1 FY26 revenue grew 24% year-on-year to about Rs. 1,23,753 lakhs, while net profit nearly doubled to Rs. 14,800 lakhs from Rs. 7,608 lakhs a year ago. Standalone Q2 FY26 revenue came in at Rs. 57,825 lakhs with PAT of Rs. 4,636 lakhs (EPS Rs. 11.93), while consolidated Q2 PAT jumped to Rs. 9,092 lakhs (EPS Rs. 24.04) from Rs. 4,469 lakhs in Q2 FY25. EBITDA margin expanded meaningfully on the back of strong subsidiary performance. Statutory auditor BSR & Co. LLP issued an unmodified limited review report, and the company operates in a single segment — Aroma Chemicals.
Sharp consolidated profit growth and margin expansion are positive for shareholders, but the parent's standalone business shrank in Q2 (revenue down ~12%, PAT down ~54%), meaning all the growth is coming from subsidiaries — worth keeping an eye on.